We will clone and express the cystic fibrosis transmembrane conductance regulator (CFTR) in insect and mammalian cells. We will develop methods to purify these two CFTRs, which will differ only in their extent of glycosylation, and establish omgeneity by 1D- and 2D-gel electrophoresis, amino acid composition, and N-terminal amino acid sequencing. the purified function of the CFTRs, proper glycsoylation and phosphorylation, development of methods for large-scale purification for use in diagnostic assays and replacement therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43DK052750-01
Application #
2018252
Study Section
Special Emphasis Panel (ZRG3-SSS-2 (01))
Program Officer
Mckeon, Catherine T
Project Start
1997-08-01
Project End
1998-01-31
Budget Start
1997-08-01
Budget End
1998-01-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
DNA Technologies, Inc.
Department
Type
DUNS #
City
Gaithersburg
State
MD
Country
United States
Zip Code
20879